Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03950245
What this trial is testing

Incretin Hormone Antagonism After Bariatric Surgery

Who this might be right for
Bariatric Surgery
Hvidovre University Hospital 36
Large-scale testing (Phase 3)Study completedNCT01185119
What this trial is testing

Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET

Who this might be right for
Healthy
University of Aarhus 10
Testing effectiveness (Phase 2)Study completedNCT05111912
What this trial is testing

Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity

Who this might be right for
Obesity
Sciwind Biosciences APAC CO Pty. Ltd. 206
Not applicableStudy completedNCT02697305
What this trial is testing

Incretin Effects of Branched Chain Amino Acids

Who this might be right for
Glucose Metabolism Disorders
Charles University, Czech Republic 18
Not applicableLooking for participantsNCT06734312
What this trial is testing

MAINTAIN (Mucosal AblatIoN Therapy After INcretins)

Who this might be right for
Obesity and Obesity-related Medical ConditionsObesity and OverweightObesity Prevention+3 more
Dr. Christopher McGowan 20
Not applicableEnded earlyNCT01934816
What this trial is testing

Incretin and KATP Channels

Who this might be right for
Healthy Subjects
Katarina Kos 2
Large-scale testing (Phase 3)Study completedNCT01733758
What this trial is testing

A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 494
Very early researchStudy completedNCT02130778
What this trial is testing

Natriuretic Effect of GLP-1in Healthy Non Obese Subjects

Who this might be right for
Sodium Excretion by Urination
Clinical Hospital Centre Zagreb 15
Not applicableNot Yet RecruitingNCT07505134
What this trial is testing

Exploring the Influence of Glucagon-like Peptide -1 (GLP-1) Medications on Food Cravings, Food Selection, and Food Intake Following Exposure to Food Advertisements

Who this might be right for
GLP - 1
Penn State University 50
Early research (Phase 1)UnknownNCT02518932
What this trial is testing

The Effect of VTC-G15 (a Pentapeptide Cleavage Product og GLP-1) on Whole Body Glucose Metabolism in Man

Who this might be right for
Insulin Resistance
Elahi, Dariush, PhD 20
Not applicableLooking for participantsNCT07736963
What this trial is testing

Discontinuation Recommendations for GLP-1 Receptor Agonists Prior to Colonoscopy

Who this might be right for
GLP-1
Fu Jen Catholic University Hospital 240
Post-approval studies (Phase 4)Study completedNCT03466021
What this trial is testing

Effects of Liraglutide in Chronic Obstructive Pulmonary Disease

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Claus Bogh Juhl 40
Not applicableStudy completedNCT07373236
What this trial is testing

The Effect of Endogenous GLP-1 on Glucagon Secretion in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Asger Lund, MD 12
Testing effectiveness (Phase 2)Study completedNCT00299871
What this trial is testing

Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Sanofi 542
Not applicableStudy completedNCT02591849
What this trial is testing

GLP-1 Effects on Insulin and Glucagon in PTDM

Who this might be right for
Post-transplant Diabetes Mellitus
Oslo University Hospital 24
Not applicableStudy completedNCT02061124
What this trial is testing

Effect of Bile Acid Sequestration on Postprandial GLP-1 Secretion, Glucose Homeostasis and Gut Microbiota

Who this might be right for
Type 2 Diabetes
University Hospital, Gentofte, Copenhagen 50
Not applicableStudy completedNCT07602803
What this trial is testing

The Effect of GLP1 Agonists on Weight Loss in BBS Cohort in the UK

Who this might be right for
Bardet-Biedl Syndrome
The Queen Elizabeth Hospital 300
Not applicableStudy completedNCT04019418
What this trial is testing

Carbohydrate Intake and Gut Hormone Release During Exercise

Who this might be right for
Obesity
Imperial College London 12
Not applicableNot Yet RecruitingNCT07558603
What this trial is testing

Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 Agonist

Who this might be right for
Laxity; Skin
Goldman, Butterwick, Fitzpatrick and Groff 50
Testing effectiveness (Phase 2)Study completedNCT02617654
What this trial is testing

Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Per-Ola Carlsson 18
Next Page